Company
United StatesThe University of Texas MD Anderson Cancer Center IRB, Houston, TX – FDA Inspections
Inspection records and compliance data for The University of Texas MD Anderson Cancer Center IRB in Houston, Texas. 3 FDA inspections on record, last inspected December 12, 2024.
Company Profile
This profile covers The University of Texas MD Anderson Cancer Center IRB based in Houston, Texas, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected August 19, 2010. Last inspected December 12, 2024.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 12, 2024 | Not classified | Biologics, Human Drugs, Medical Devices & Rad Health | 1258173 |
| March 12, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1085580 |
| August 19, 2010 | NAI | Biologics · Bioresearch Monitoring | 679432 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
University Of Pennsylvania, Office of the Institutional Review Boards
Carilion Clinic IRB
Charles Drew University of Medicine & Science IRB
Boston Children's Hospital IRB
Walter Reed Army Institute of Research (WRAIR) IRB
ProHealth Care IRB
City Of Hope National Medical Center IRB
Univ Nebraska Med Center IRB
East Tennessee Children's Hospital IRB
Louisiana State University Health Sciences Center-Shreveport IRB
Company Information
Name
The University of Texas MD Anderson Cancer Center IRB
FEI Number
1626261
Address
7007 Bertner Ave Unit 1637 Ofc Of, Houston, Texas 77030, United States
Country
United States
ID: 28c4342a-a3d2-4f87-98df-440b0129175f